| scholarly article | Q13442814 |
| P50 | author | Eric Boerwinkle | Q28050857 |
| Ron C Hoogeveen | Q60644631 | ||
| Aaron R. Folsom | Q71098091 | ||
| Thomas H Mosley | Q88217415 | ||
| Brad Astor | Q88438848 | ||
| Lloyd Chambless | Q92172520 | ||
| Christie M. Ballantyne | Q98665268 | ||
| James A. de Lemos | Q114308408 | ||
| Vijay Nambi | Q114358599 | ||
| Anita Deswal | Q117270209 | ||
| Gerardo Heiss | Q30004039 | ||
| Josef Coresh | Q30436517 | ||
| Salim S. Virani | Q37370038 | ||
| P2093 | author name string | Pothur R Srinivas | |
| David Aguilar | |||
| Xiaoxi Liu | |||
| Sunil Agarwal | |||
| P2860 | cites work | A method for checking regression models in survival analysis based on the risk score. | Q52314719 |
| ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Gu | Q58975447 | ||
| Profile for estimating risk of heart failure | Q77889326 | ||
| National study of physician awareness and adherence to cardiovascular disease prevention guidelines | Q28217358 | ||
| Heart disease and stroke statistics--2012 update: a report from the American Heart Association | Q29547909 | ||
| Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond | Q29614697 | ||
| The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators | Q29614947 | ||
| Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association | Q30080021 | ||
| Plasma natriuretic peptide levels and the risk of cardiovascular events and death | Q34298401 | ||
| Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association's strategic Impact Goal through 2020 and beyond | Q34615977 | ||
| Cardiac troponin T measured by a highly sensitive assay predicts coronary heart disease, heart failure, and mortality in the Atherosclerosis Risk in Communities Study | Q34768805 | ||
| Community prevalence of ideal cardiovascular health, by the American Heart Association definition, and relationship with cardiovascular disease incidence | Q34976346 | ||
| Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers | Q35927436 | ||
| Prediction of incident heart failure in general practice: the Atherosclerosis Risk in Communities (ARIC) Study | Q36143273 | ||
| ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 G | Q36259700 | ||
| Association of serial measures of cardiac troponin T using a sensitive assay with incident heart failure and cardiovascular mortality in older adults. | Q36574151 | ||
| Prevalence and prognostic significance of heart failure stages: application of the American College of Cardiology/American Heart Association heart failure staging criteria in the community | Q36758041 | ||
| Reporting of estimated GFR in the primary care clinic | Q36808187 | ||
| Evidence for the use of B-type natriuretic peptides for screening asymptomatic populations and for diagnosis in primary care | Q36962685 | ||
| Sources of variability in measurements of cardiac troponin T in a community-based sample: the atherosclerosis risk in communities study | Q37055493 | ||
| Absolute and attributable risks of heart failure incidence in relation to optimal risk factors | Q37087291 | ||
| Incident heart failure prediction in the elderly: the health ABC heart failure score | Q37356725 | ||
| Two Years After a Quality Improvement Intervention for Chronic Kidney Disease Care in a Primary Care Office | Q37799196 | ||
| Early detection of CKD: the benefits, limitations and effects on prognosis | Q37895459 | ||
| Index for rating diagnostic tests | Q39605675 | ||
| Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors | Q39605793 | ||
| Estimation of time-dependent area under the ROC curve for long-term risk prediction | Q40381904 | ||
| Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population | Q41666469 | ||
| Acceptance of guideline recommendations and perceived implementation of coronary heart disease prevention among primary care physicians in five European countries: the Reassessing European Attitudes about Cardiovascular Treatment (REACT) survey | Q44214992 | ||
| Several methods to assess improvement in risk prediction models: Extension to survival analysis | Q44667332 | ||
| Stability of N-terminal pro-brain natriuretic peptide after storage frozen for one year and after multiple freeze-thaw cycles | Q48222140 | ||
| The use of computerized decision support systems in preventive cardiology--principal results from the national PRECARD survey in Denmark. | Q50579494 | ||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | heart failure | Q181754 |
| biomarker | Q864574 | ||
| atherosclerosis | Q12252367 | ||
| P304 | page(s) | 1802-1810 | |
| P577 | publication date | 2013-09-13 | |
| P1433 | published in | Clinical Chemistry | Q849687 |
| P1476 | title | Troponin T and N-terminal pro-B-type natriuretic peptide: a biomarker approach to predict heart failure risk--the atherosclerosis risk in communities study | |
| P478 | volume | 59 |
| Q37556051 | 25-Hydroxyvitamin D Levels and Markers of Subclinical Myocardial Damage and Wall Stress: The Atherosclerosis Risk in Communities Study |
| Q40274229 | An NPPB Promoter Polymorphism Associated With Elevated N-Terminal pro-B-Type Natriuretic Peptide and Lower Blood Pressure, Hypertension, and Mortality |
| Q38950900 | Assessing Cardiovascular Risk and Testing in Type 2 Diabetes |
| Q89958685 | Cardiac Biomarkers and Subsequent Risk of Hospitalization With Bleeding in the Community: Atherosclerosis Risk in Communities Study |
| Q62471522 | Cardiac ScoreCard: A diagnostic multivariate index assay system for predicting a spectrum of cardiovascular disease |
| Q64109352 | Cardioprotective Effect of the Mitochondrial Unfolded Protein Response During Chronic Pressure Overload |
| Q88747656 | Cardiovascular Disease Prevention: Training Opportunities, the Challenges, and Future Directions |
| Q38543356 | Cardiovascular biomarkers and sex: the case for women |
| Q38762394 | Combination of high-sensitivity troponin I and N-terminal pro-B-type natriuretic peptide predicts future hospital admission for heart failure in high-risk hypertensive patients with preserved left ventricular ejection fraction |
| Q51655639 | Comparison of the Effects of Levosimendan Dobutamine and Vasodilator Therapy on Ongoing Myocardial Injury in Acute Decompensated Heart Failure. |
| Q96681708 | Elevated N-terminal prohormone of brain natriuretic peptide among persons living with HIV in a South African peri-urban township |
| Q92053515 | Evidence for a Direct Harmful Effect of Alcohol on Myocardial Health: A Large Cross-Sectional Study of Consumption Patterns and Cardiovascular Disease Risk Biomarkers From Northwest Russia, 2015 to 2017 |
| Q51766256 | Global ECG Measures and Cardiac Structure and Function: The ARIC Study (Atherosclerosis Risk in Communities). |
| Q57530015 | High-Sensitivity Troponin T and Incident Heart Failure in Older Men: British Regional Heart Study |
| Q40401170 | High-sensitivity cardiac troponin I and NT-proBNP as predictors of incident dementia and Alzheimer's disease: the FINRISK Study |
| Q30583705 | High-sensitivity cardiac troponin T and cognitive function and dementia risk: the atherosclerosis risk in communities study |
| Q36407050 | High-sensitivity troponin I and amino-terminal pro--B-type natriuretic peptide predict heart failure and mortality in the general population |
| Q36881933 | Histamine H2 Receptor Antagonists, Left Ventricular Morphology, and Heart Failure Risk: The MESA Study |
| Q37026476 | Influence of cigarette smoking on cardiac biomarkers: the Atherosclerosis Risk in Communities (ARIC) Study |
| Q90201394 | Longitudinal increases in blood biomarkers of inflammation or cardiovascular disease and the incidence of venous thromboembolism |
| Q93192737 | Metabolic remodeling induced by mitokines in heart failure |
| Q40266203 | Multimodality Strategy for Cardiovascular Risk Assessment: Performance in 2 Population-Based Cohorts |
| Q89184187 | Nanostructured aptamer-based sensing platform for highly sensitive recognition of myoglobin |
| Q47711449 | No smoke without fire? |
| Q36992652 | Predicting Heart Failure With Preserved and Reduced Ejection Fraction: The International Collaboration on Heart Failure Subtypes |
| Q100525984 | Preoperative cardiac troponin below the 99th-percentile upper reference limit and 30-day mortality after noncardiac surgery |
| Q47661463 | Prevention of "Failure": Is It a Failure of Prevention? |
| Q53760291 | Propensity of people of African descent towards hypertension-associated cardiovascular pathologies. |
| Q36141360 | Racial differences in circulating natriuretic peptide levels: the atherosclerosis risk in communities study |
| Q50145984 | SES, Heart Failure, and N-terminal Pro-b-type Natriuretic Peptide: The Atherosclerosis Risk in Communities Study |
| Q52382384 | Short-Term Global Cardiovascular Disease Risk Prediction in Older Adults. |
| Q51245470 | Troponin and BNP are markers for subsequent non-ischaemic congestive heart failure: the Caerphilly Prospective Study (CaPS). |
| Q45880675 | Troponin elevations only detected with a high-sensitivity assay: clinical correlations and prognostic significance |
| Q38734398 | Troponin in Cardiovascular Disease Prevention: Updates and Future Direction |
Search more.